We require Idiopathic Pulmonary Fibrosis (IPF) patients for a new study.
This study will be 2 to 4 visits to the unit and two phone calls, and will be spread over approximately 4 to 8 weeks.
A payment will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
If you would like to find out more about this study please call our Recruitment Team on 0800 655 6553 or 0161 946 4050 and quote study MEU 23/447.
Alternatively, you can register your interest via the form below.
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations. Learn more at www.iqvia.com.
Contact us…
The Medicines Evaluation Unit
The Langley Building
Southmoor Road
Wythenshawe Hospital
Manchester
M23 9QZ
T: 0800 655 6553